Concepedia

Publication | Open Access

Phase II study of oral S‐1 for treatment of metastatic colorectal carcinoma

116

Citations

26

References

2004

Year

Abstract

Orally administered S-1 is active against metastatic colorectal carcinoma and has an acceptable toxicity profile. This promising agent has the potential to become a valuable chemotherapeutic option.

References

YearCitations

Page 1